These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33217785)

  • 1. Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration.
    Guerville F; De Souto Barreto P; Coley N; Andrieu S; Mangin JF; Chupin M; Payoux P; Ousset PJ; Rolland Y; Vellas B;
    J Am Geriatr Soc; 2021 Mar; 69(3):651-659. PubMed ID: 33217785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.
    Petersen RC; Wiste HJ; Weigand SD; Rocca WA; Roberts RO; Mielke MM; Lowe VJ; Knopman DS; Pankratz VS; Machulda MM; Geda YE; Jack CR
    JAMA Neurol; 2016 Jan; 73(1):85-92. PubMed ID: 26595683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.
    Huijbers W; Mormino EC; Schultz AP; Wigman S; Ward AM; Larvie M; Amariglio RE; Marshall GA; Rentz DM; Johnson KA; Sperling RA
    Brain; 2015 Apr; 138(Pt 4):1023-35. PubMed ID: 25678559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults.
    Biddle KD; d'Oleire Uquillas F; Jacobs HIL; Zide B; Kirn DR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    Am J Geriatr Psychiatry; 2019 Nov; 27(11):1247-1256. PubMed ID: 31248770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.
    Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Bourgeat P; Martins RN; Salvado O; Rowe CC; Masters CL; Maruff P;
    J Mol Neurosci; 2016 Nov; 60(3):362-370. PubMed ID: 27586003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults.
    Lu WH; Giudici KV; Morley JE; Guyonnet S; Parini A; Aggarwal G; Nguyen AD; Li Y; Bateman RJ; Vellas B; de Souto Barreto P;
    Geroscience; 2022 Jun; 44(3):1489-1503. PubMed ID: 35445358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.
    Gatchel JR; Rabin JS; Buckley RF; Locascio JJ; Quiroz YT; Yang HS; Vannini P; Amariglio RE; Rentz DM; Properzi M; Donovan NJ; Blacker D; Johnson KA; Sperling RA; Marshall GA;
    JAMA Netw Open; 2019 Aug; 2(8):e198964. PubMed ID: 31397865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults.
    Giudici KV; de Souto Barreto P; Guyonnet S; Li Y; Bateman RJ; Vellas B;
    JAMA Netw Open; 2020 Dec; 3(12):e2028634. PubMed ID: 33331917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
    Biddle KD; Jacobs HIL; d'Oleire Uquillas F; Zide BS; Kirn DR; Properzi MR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    JAMA Netw Open; 2020 Feb; 3(2):e200121. PubMed ID: 32101313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.
    Sanchez-Sanchez JL; Giudici KV; Guyonnet S; Delrieu J; Li Y; Bateman RJ; Parini A; Vellas B; de Souto Barreto P;
    Alzheimers Res Ther; 2022 Jan; 14(1):5. PubMed ID: 34996522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort.
    Murray AM; Thao LTP; Ryan J; Wolfe R; Wetmore JB; Woods RL; Polkinghorne KR
    Kidney360; 2022 Mar; 3(3):435-445. PubMed ID: 35582189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    Vassilaki M; Aakre JA; Kremers WK; Mielke MM; Geda YE; Machulda MM; Knopman DS; Coloma PM; Schauble B; Vemuri P; Lowe VJ; Jack CR; Petersen RC; Roberts RO
    J Am Geriatr Soc; 2018 Dec; 66(12):2274-2281. PubMed ID: 30462843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.